Monica Colvin, M.D., is an associate professor of medicine in the Cardiovascular Division at the University of Michigan. She received her medical degree from the University of Alabama and completed her general cardiology fellowship at the University of Miami, as well as a fellowship in advanced heart failure at Cleveland Clinic. Dr. Colvin completed a master’s degree in clinical research at the University of Minnesota School of Public Health and served as the medical director of heart transplant at the University of Minnesota. She is currently the director of the Heart Failure Network Strategy in the Division of Cardiovascular Medicine at the University of Michigan. Dr. Colvin is also the heart clinical specialist for the Scientific Registry of Transplant Recipients where she is involved in heart allocation. Her scholarly work focuses on improving post-transplant outcomes, and detecting and treating cardiac allograft vasculopathy.
Philosophy of Care
“Caring for heart failure patients allows me to provide more comprehensive cardiovascular care to my patients, which frequently involves lifestyle modifications and dietary management,” said Dr. Colvin. “I not only enjoy helping my patients manage their disease but also enjoy helping them develop lifestyle changes. In addition, providing heart failure care allows me to act as a family physician with a focus. Most care is lifelong, whether patients are managed medically, with a heart transplant or with a left ventricular assist device (LVAD). This means that I have the opportunity to really get to know my patients over time and to witness important personal milestones in their lives that are extremely dear to them, such as births, marriages and graduations.”
“The MidMichigan Heart Failure team is knowledgeable, approachable, and dedicated to providing the highest level of heart failure care,” she added. “It is a pleasure to be a part of the team.”
Special Interests and Procedures
Dr. Colvin’s clinical focus is advanced heart failure, heart transplant and mechanical circulatory support. She has been clinically involved in heart transplant and LAVDs for more than 15 years and has participated in research trials involving mechanical circulatory support dating back to the most pivotal studies. She brings this experience and expertise to the University of Michigan and MidMichigan Medical Center - Midland where she enjoys caring for patients with end stage heart failure and assisting them in determining the appropriate management, whether that includes transplant, LVAD, or medication. She is dedicated to educating her patients about their conditions so that they may participate actively in the process